Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 17, Pages 5957
Publisher
MDPI AG
Online
2020-08-19
DOI
10.3390/ijms21175957
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity
- (2019) Thi Thinh Nguyen et al. Scientific Reports
- Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients
- (2019) Nuria Álvarez-Sánchez et al. Scientific Reports
- Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients
- (2019) Michal Bijak et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential
- (2019) Frank Madeo et al. Cell Metabolism
- Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model
- (2019) Seyed Hossein Hosseini Largani et al. JOURNAL OF MOLECULAR HISTOLOGY
- Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
- (2019) Olga Horakova et al. Scientific Reports
- Coagulation Pathways in Neurological Diseases: Multiple Sclerosis
- (2019) Nicole Ziliotto et al. Frontiers in Neurology
- The changing course of multiple sclerosis
- (2019) Melinda Magyari et al. CURRENT OPINION IN NEUROLOGY
- Metformin Inhibits the Type 1 IFN Response in Human CD4+ T Cells
- (2019) Anton A. Titov et al. JOURNAL OF IMMUNOLOGY
- Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
- (2019) Hugo Gonzalo et al. Frontiers in Neuroscience
- Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells
- (2019) Björn Neumann et al. Cell Stem Cell
- Treatment with Metformin and Combination of Metformin Plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial
- (2019) Durr-e-Shewar Ali et al. HORMONE AND METABOLIC RESEARCH
- Assessment of Mitochondrial Dysfunction in Experimental Autoimmune Encephalomyelitis (EAE) Models of Multiple Sclerosis
- (2019) Xiulin Ng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA
- (2019) Judith Derdelinckx et al. Journal of Neuroinflammation
- Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis
- (2019) Magdalena Markowicz-Piasecka et al. MOLECULES
- Hemostasis biomarkers in multiple sclerosis
- (2018) N. Ziliotto et al. EUROPEAN JOURNAL OF NEUROLOGY
- Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model
- (2018) Inderjit Singh et al. IMMUNOLOGY
- The Balance of Th17 versus Treg Cells in Autoimmunity
- (2018) Gap Lee INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment
- (2018) Tao Tao et al. BMC Endocrine Disorders
- Endothelial function and dysfunction: Impact of metformin
- (2018) Asma Nafisa et al. PHARMACOLOGY & THERAPEUTICS
- Multiple sclerosis - a review
- (2018) R. Dobson et al. EUROPEAN JOURNAL OF NEUROLOGY
- Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism
- (2018) Hideya Shintani et al. Nutrients
- The proportion of peripheral regulatory T cells in patients with Multiple Sclerosis: A meta-analysis
- (2018) Yu-Feng Li et al. Multiple Sclerosis and Related Disorders
- Interactions between platelets and leukocytes in pathogenesis of multiple sclerosis
- (2018) Angela Dziedzic et al. Advances in Clinical and Experimental Medicine
- Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome
- (2017) Jiao Wang et al. MEDICINE
- Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients
- (2017) Agnieszka Morel et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease
- (2017) Wei-Hao Hsu et al. Oncotarget
- The effect of metformin (M) on overall survival (OS) of patients (Pts) with colorectal cancer (CRC) treated with chemotherapy (CTX).
- (2017) M. Bansal et al. JOURNAL OF CLINICAL ONCOLOGY
- The suppressive effects of metformin on inflammatory response of otitis media model in human middle ear epithelial cells
- (2016) Jae Gu Cho et al. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice
- (2016) Yafei Sun et al. JOURNAL OF NEUROIMMUNOLOGY
- Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson's disease dementia
- (2016) Yi Xing et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications
- (2016) Giordani Rodrigues Dos Passos et al. MEDIATORS OF INFLAMMATION
- Metformin-associated lactic acidosis: Current perspectives on causes and risk
- (2016) Ralph DeFronzo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis
- (2016) Bożena Adamczyk et al. Oxidative Medicine and Cellular Longevity
- Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression
- (2016) Zhong’e Zhou et al. Journal of Diabetes Research
- Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis
- (2016) Laura Negrotto et al. JAMA Neurology
- The effects of thrombomodulin and activated protein C on the pathogenesis of multiple sclerosis
- (2016) Ece Balkuv et al. Multiple Sclerosis and Related Disorders
- Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states
- (2016) Hye Suk Kang et al. Scientific Reports
- Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis
- (2016) Mona Sadeghian et al. Scientific Reports
- Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release
- (2016) Guang Xin et al. Scientific Reports
- Metformin Action: Concentrations Matter
- (2015) Ling He et al. Cell Metabolism
- FOXP3+ regulatory T cells and their functional regulation
- (2015) Zhiyuan Li et al. Cellular & Molecular Immunology
- Unexpectedly long half-life of metformin elimination in cases of metformin accumulation
- (2015) F. Kajbaf et al. DIABETIC MEDICINE
- Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis
- (2015) H. Xu et al. ONCOLOGIST
- Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage
- (2015) Agnieszka Morel et al. Oxidative Medicine and Cellular Longevity
- Targeting metabolism for lupus therapy
- (2015) Manan M. Mehta et al. Science Translational Medicine
- Normalization of CD4 + T cell metabolism reverses lupus
- (2015) Yiming Yin et al. Science Translational Medicine
- Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation
- (2015) Jae Kyu Ryu et al. Nature Communications
- Haemostatic Effects of Metformin in Simvastatin-Treated Volunteers with Impaired Fasting Glucose
- (2014) Robert Krysiak et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis
- (2014) Matías Sáenz-Cuesta et al. Biomarkers in Medicine
- Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function
- (2014) Beatriz Marcos-Ramiro et al. BMC NEUROSCIENCE
- Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics
- (2014) Oscar G. Vidaurre et al. BRAIN
- Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain
- (2014) Maggie S.Y. Yeung et al. CELL
- The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis
- (2014) Maja Živković et al. DISEASE MARKERS
- New Multiple Sclerosis Phenotypic Classification
- (2014) Fred D. Lublin EUROPEAN NEUROLOGY
- Regulatory T cells in autoimmune neuroinflammation
- (2014) Markus Kleinewietfeld et al. IMMUNOLOGICAL REVIEWS
- Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion
- (2014) Yanqun Liu et al. Journal of Neuroinflammation
- The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink
- (2014) P. J. H. L. Peeters et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance
- (2014) Robert Krysiak et al. Pharmacological Reports
- AMP-Activated Protein Kinase Signaling Protects Oligodendrocytes that Restore Central Nervous System Functions in an Experimental Autoimmune Encephalomyelitis Model
- (2013) Ajaib S. Paintlia et al. AMERICAN JOURNAL OF PATHOLOGY
- ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages
- (2013) Yan Zhang et al. CELL RESEARCH
- High risk of cardiovascular diseases after diagnosis of multiple sclerosis
- (2013) Elham Jadidi et al. Multiple Sclerosis Journal
- Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling
- (2013) Kaylene M. Young et al. NEURON
- Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
- (2013) Michelle M. Mielke et al. PLoS One
- Metformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages
- (2013) Bobae Hyun et al. Immune Network
- Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
- (2012) C. Algire et al. Cancer Prevention Research
- Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis
- (2012) Harald F. Langer et al. CIRCULATION RESEARCH
- Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
- (2012) DIABETES CARE
- Altered frequency of T regulatory cells is associated with disability status in relapsing–remitting multiple sclerosis patients
- (2012) Lasse Bjerg et al. JOURNAL OF NEUROIMMUNOLOGY
- Risk of venous thrombosis in patients with major illnesses: results from the MEGA study
- (2012) G. OCAK et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Multiple Sclerosis and Risk of Venous Thromboembolism: A Population-Based Cohort Study
- (2012) Steffen Christensen et al. NEUROEPIDEMIOLOGY
- Mechanism of Oxidative Stress in Neurodegeneration
- (2012) Sonia Gandhi et al. Oxidative Medicine and Cellular Longevity
- The effect of metformin on mean platelet volume in dıabetıc patients
- (2012) Ilhan Dolasık et al. PLATELETS
- Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
- (2012) Dimitrios Davalos et al. Nature Communications
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Mean Platelet Volume: A Link Between Thrombosis and Inflammation?
- (2011) Armen Yuri Gasparyan et al. CURRENT PHARMACEUTICAL DESIGN
- Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
- (2011) K. J. Lipska et al. DIABETES CARE
- Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3− and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner
- (2011) Samuel Huber et al. IMMUNITY
- Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden
- (2011) Bengt Zöller et al. LANCET
- Review article: Coagulation and fibrinolysis in diabetes
- (2010) SH Alzahrani et al. Diabetes & Vascular Disease Research
- Risk of Arterial Cardiovascular Diseases in Patients with Multiple Sclerosis: A Population-Based Cohort Study
- (2010) Christian Fynbo Christiansen et al. NEUROEPIDEMIOLOGY
- Is multiple sclerosis a mitochondrial disease?
- (2009) Peizhong Mao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis
- (2009) N. Nath et al. JOURNAL OF IMMUNOLOGY
- A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis
- (2009) Claudia C. Kaiser et al. JOURNAL OF NEUROIMMUNOLOGY
- Neuronal PPAR Deficiency Increases Susceptibility to Brain Damage after Cerebral Ischemia
- (2009) X. Zhao et al. JOURNAL OF NEUROSCIENCE
- Oxidative stress induces degradation of mitochondrial DNA
- (2009) Inna Shokolenko et al. NUCLEIC ACIDS RESEARCH
- Risk of deep venous thrombosis (DVT) in bedridden or wheelchair-bound multiple sclerosis patients: A prospective study
- (2009) G. Arpaia et al. THROMBOSIS RESEARCH
- A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis
- (2008) David Wheeler et al. BRAIN
- Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study
- (2008) Shinji Sakaue et al. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A nested case-control analysis
- (2008) M. Bodmer et al. DIABETES CARE
- Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis
- (2008) Laura Piccio et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease
- (2008) Richard A. O'Connor et al. JOURNAL OF NEUROIMMUNOLOGY
- Evidence of platelet activation in multiple sclerosis
- (2008) William A Sheremata et al. Journal of Neuroinflammation
- Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity
- (2008) R.E. Gonsette JOURNAL OF THE NEUROLOGICAL SCIENCES
- PPAR-γ: Therapeutic Potential for Multiple Sclerosis
- (2008) Paul D. Drew et al. PPAR Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now